Evidence map›Paper›PMID 40324002›Full record

ArticlePloS one2025

The costs of wind energy permitting compliance actions for regulated bats in the US.

Christian Newman, Katie C Surrey

Expression of concernAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Christian NewmanElectric Power Research Institute, Palo Alto, California94304, United States of America.
Katie C SurreyElectric Power Research Institute, Palo Alto, California94304, United States of America.ORCID https://orcid.org/0000-0002-5659-8369

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The wind industry's expansion in North America due to the need to provide clean energy is leading to increased regulatory concern for bats, particularly those that are endangered due to white-nose syndrome. The projected growth of installed wind capacity overlaps extensively with the ranges of several endangered and potentially regulated bat species. Wind energy operators in the US can comply with the Endangered Species Act (ESA) by submitting a Habitat Conservation Plan (HCP) and Incidental Take Permit (ITP) to the U.S. Fish and Wildlife Service. HCP documents include wind project overviews, estimates for incidental take (e.g., unavoidable fatalities), outline minimization and compensatory mitigation measures to avoid take, and often include estimated cost information for actions to implement the HCP/ITP. However, the lack of insight into specific cost data, combined with the lengthy ITP application process, has potentially led to the perception that ESA compliance imposes a costly regulatory burden on the private sector, deterring motivation for voluntary compliance. Resulting from the absence of routine reporting practices, it is not known how much it costs for companies to comply with ESA listings, nor is there a standardized database of compliance costs or a method for estimating them. This analysis of 25 publicly available project-specific HCPs published through 2022 establishes one approach to conceptualizing these costs and determined the median total cost for an HCP to be approximately $4.68 million (USD), with a notable discrepancy between the median costs for compensatory mitigation cost ($1.64 million) and fatality monitoring ($3.15 million). This analysis also created a general linear model that can be used to estimate potential project-specific costs, and overall provides better insight into the costs of complying with the ESA by identifying variables that might affect compliance costs, and estimating future costs for the wind industry.

Indexed as

ChiropteraConservation of Natural ResourcesEndangered SpeciesWindAnimalsEcosystemUnited States

Identifiers

PMID40324002
PMCPMC12083899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.